TCL Archive FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer September 24, 1999
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block March 18, 1977